[一个患有末期肌缩侧面硬化症的患者的肌缩综合征]
E A Kovrazhkina1, A V Serdyuk2, O D Razinskaya2
1Federal Center for Brain and Neurotechnology, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|July 25, 2023
概括
肌缩侧面硬化症 (ALS) 很少会与肌综合征发生,呈现类似的症状,但需要不同的诊断和治疗. 这一案例凸显了区分这些神经疾病的挑战.
科学领域:
- 神经学 神经学
- 临床神经科学 临床神经科学
背景情况:
- 肌缩侧面硬化症 (ALS) 和肌痛性硬化症共享重叠的临床症状,使诊断和治疗复杂化.
- 异常罕见的是ALS和肌痛性骨髓炎的同时发生,而伴随着肌痛性综合征的ALS是最常见的表现.
研究的目的:
- 介绍一例临床病例,该病例是患有末期ALS和共存的肌综合征的患者.
- 讨论这种综合性疾病的原发病理的主要理论.
- 概述差异性诊断策略,以区分ALS和肌痛性骨髓炎.
主要方法:
- 案例报告的呈现方式.
- 对ALS和骨髓灰质炎综合征的发病理论的审查.
- 关于ALS和严重骨髓灰质炎的差异诊断标准的讨论.
主要成果:
- 本案例涉及一位患有晚期ALS的患者,该患者表现出肌综合征的特征.
- 伴随ALS的肌综合征的关键特征包括病态肌肉疲劳,白天症状变化,对neostigmine的部分反应和电肌图学M波下降.
结论:
- 虽然ALS和肌肌综合征的同时发生很少见,但由于症状重叠,需要仔细的诊断评估.
- 了解不同的特征和诊断标记对于适当的患者管理和治疗规划至关重要.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
Disorders of the Skeletal Muscle
995
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
995
Cross-bridge Cycle
117.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.7K
Chemical Synapses
8.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.9K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K


